Anuncia Announces Successful First-in-Human Use of the Alivio ReFlow™ Ventricular System for Treatment of Hydrocephalus ›
Alcyone Lifesciences Receives FDA Clearance for the Alivio System for the Treatment of Hydrocephalus ›
Alcyone Lifesciences Completes Spin-Off of Hydrocephalus Business, Anuncia ›
The average cost of a shunt-related hospital admission is1
$35,816
The incidence of shunt malfunction within two years is2
50%
The probability of shunt malfunction within 12 years is3
81%
The total cost of shunt surgeries in the U.S. exceeds4
$2b
Big Innovation & Peace of Mind in a small package
Discover the technology behind our patent-protected ReFlow™* Ventricular system, and find out what the future holds for Anuncia.
"CSF shunts have saved the lives of thousands of children and adolescents and reduced morbidity in tens of thousands more. However, efforts to limit the frequency and potential impact of shunt failure for these patients has fallen short. Anuncia's innovative technology is designed to restore flow by mimicking the cough reflex we all use to protect our airways. It is encouraging that it works in the operating room just like it does in bench-top and in vivo studies."
DR. JOSEPH R. MADSEN
Co-Founder, Anuncia & Pediatric Neurosurgeon
Where to find us:
The Society for Research in hydrocephalus and Spina Bifida (SRHSB)
June 25th, 2019 – June 29th, 2019
Canary Islands
ISHCSF
September 13th, 2019 – September 16th, 2019
Vancouver, CA
Hydrocephalus Walk
October 6th, 2019
Medford, MA
HA Connect
June 25th, 2020 – June 27th, 2020
Houston, TX
Dr. Joseph Madsen and advisor Jonathan Fleming were recently honored at the 2017 Pediatric Innovation Founder's Dinner for their efforts to bring innovative technology to the clinic to treat Hydrocephalus.
Dr. Madsen's award acceptance speech, in which he speaks about our breakthrough ReFlow™ Ventricular System
The views expressed in this video are those of Joseph R. Madsen, MD and do not necessarily reflect the views of Anuncia, our partners, collaborators, representatives, or subsidiaries.
